Gonak Hypromellose (Akorn, Inc.)


Welcome to the PulseAid listing for the Gonak Hypromellose drug offered from Akorn, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Hypromellose 2906 (4000 MPA.S) and Hypromellose 2906 (50 MPA.S)
SUBSTANCE NAME: HYPROMELLOSE 2906 (4000 MPA.S); HYPROMELLOSE 2906 (50 MPA.S)
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 1997-01-01
END MARKETING DATE: 0000-00-00


Gonak Hypromellose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGonak Hypromellose from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25; 25(mg/mL; mg/mL)
START MARKETING DATE: 1997-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-064_0bf13d29-b5ce-4a34-a6a5-4883a13487b1
PRODUCT NDC: 17478-064
APPLICATION NUMBER:

Other HYPROMELLOSE 2906 (4000 MPA.S); HYPROMELLOSE 2906 (50 MPA.S) Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Gonak Hypromellose